Matthew Zarth

Matthew Zarth

Auto-generated profile, based on publicly available information

Matthew Zarth

Anesthesiology, University of Mississippi Medical Center, Jackson, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2020 in Cureus
Verified
Journal Article
Open access
PDF file
BHBryan Hierlmeier
Bryan Hierlmeier
GOGalina Ostrovsky
Galina Ostrovsky
MZMatthew Zarth
Matthew Zarth
Amplatzer Atrial Septal Occluder device has been routinely and successfully used as a percutaneous alternative to cardiac surgery for closure of atrial septal defects. It has shown to the safe with a low complication profile. Complications that most commonly occur with atrial septal defect (ASD) closure devices include malposition or embolization, residual shunt, atrial arrhythmias, thrombosis over the vena cava or atrium, erosion and perforation of the heart, and infective endocarditis. The most common complications associated with an ASD occluder device appear to be embolization and malposition with embolization usually occurring in the main pulmonary artery. We present a case in which the ASO device, AmplatzerTM (Abbott, USA), embolized into the left ventricle.